Home/Pharvaris/Anne Lesage

AL

Anne Lesage

Scientist/Author

Therapeutic Areas

Hereditary Angioedema (HAE)Acquired Angioedema (AAE-C1INH)

Pharvaris Pipeline

Drug	Indication	Phase
Deucrictibant (PHVS719 XR)	Prophylactic Treatment of HAE	Phase 3
Deucrictibant (PHVS416 IR)	On-Demand Treatment of HAE	Phase 3
Deucrictibant	Treatment of Acquired Angioedema (AAE-C1INH)	Phase 3

Leadership Team at Pharvaris

Clinical Trial Investigator/Author

Clinical Trial Investigator/Author

Emel Aygören-Pürsün

Clinical Trial Investigator/Author

Scientist/Author

Scientist/Author

View full Pharvaris profile